Cardiome Pharma Corporation Net Profit Margin 2016-2019 | CORV
Cardiome Pharma Corporation net profit margin from 2016 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2019-09-30 | $0.03B | $-0.04B | -120.00% |
| 2019-06-30 | $0.03B | $-0.03B | -106.67% |
| 2019-03-31 | $0.03B | $-0.02B | -58.62% |
| 2018-12-31 | $0.03B | $-0.02B | -55.17% |
| 2018-09-30 | $0.03B | $-0.02B | -66.67% |
| 2018-06-30 | $0.03B | $-0.02B | -69.23% |
| 2018-03-31 | $0.03B | $-0.03B | -123.08% |
| 2017-12-31 | $0.02B | $-0.03B | -125.00% |
| 2017-09-30 | $0.02B | $-0.03B | -116.67% |
| 2017-06-30 | $0.02B | $-0.03B | -113.04% |
| 2017-03-31 | $0.02B | $-0.03B | -108.70% |
| 2016-12-31 | $0.03B | $-0.02B | -80.00% |
| 2016-09-30 | $0.02B | $-0.02B | -91.30% |
| 2016-06-30 | $0.02B | $-0.02B | -95.65% |
| 2016-03-31 | $0.02B | $-0.02B | -91.30% |
| 2015-12-31 | $0.02B | $-0.02B | -114.29% |
